Thromboprophylaxis Management in Critically Ill Patients

Introduction to Thromboprophylaxis

The Surviving Sepsis Campaign recommends that patients with severe sepsis or septic shock receive venous thromboembolism (VTE) prophylaxis due to high thrombotic risk from immobility, inflammation, and critical illness 1, 2
Septic patients have significantly elevated VTE risk, with studies showing DVT incidence of 26-29% without prophylaxis versus 4-13% with prophylaxis 3

Active gastrointestinal bleeding is an absolute contraindication to pharmacologic thromboprophylaxis and requires mechanical prophylaxis as the sole intervention until bleeding resolves 1, 2
Initiate intermittent pneumatic compression devices immediately, as these have proven efficacy and are specifically recommended when anticoagulation is contraindicated 1, 2
Graduated compression stockings can be added unless contraindicated by peripheral vascular disease or severe edema 1, 2

Unfractionated heparin (UFH) 5,000 units subcutaneously every 8-12 hours is the preferred agent for patients with severe renal impairment, as it does not accumulate and does not require renal clearance 1, 2
If dalteparin is available, it can be used as an alternative low molecular weight heparin (LMWH) with low renal metabolism, though UFH remains the gold standard in this setting 1, 2

Once pharmacologic prophylaxis is initiated, continue mechanical prophylaxis concurrently - the combination of pharmacologic and mechanical prophylaxis is recommended for critically ill septic patients whenever possible 1, 2

Do not use LMWH in patients with severe renal impairment (CKD 5) - despite being preferred in general septic populations, severe renal impairment causes LMWH accumulation and increased bleeding risk 1, 2
Do not delay mechanical prophylaxis - waiting for bleeding to resolve before starting any prophylaxis increases VTE risk unnecessarily 1, 2
Stress ulcer prophylaxis should be considered in patients with multiple risk factors (mechanical ventilation implied by ICU status, septic shock, coagulopathy risk) and should receive proton pump inhibitor or H2-receptor antagonist 1, 2

The American College of Cardiology recommends that all septic patients without contraindications should receive pharmacologic DVT prophylaxis, with LMWH preferred over unfractionated heparin due to superior efficacy and safety profile 4
LMWH is strongly recommended as the preferred agent over unfractionated heparin for VTE prophylaxis in septic patients, with standard dosing of Enoxaparin 40 mg subcutaneously once daily 4, 5
LMWH demonstrates superior efficacy with reduced thromboembolic events (5.5% vs 14.9% with placebo) 5
LMWH has a lower risk of heparin-induced thrombocytopenia compared to UFH 6

Use UFH when LMWH is contraindicated, particularly in severe renal impairment (creatinine clearance <30 mL/min), with dosing of 5,000 units subcutaneously either two or three times daily 7, 5, 6, 8
UFH is inexpensive and has demonstrated safety in critically ill patients, with studies showing mortality reduction (7.8% vs 10.9%) and decreased DVT incidence (4% vs 26%) with UFH prophylaxis 5, 6, 8

For patients with contraindications to anticoagulation, use intermittent pneumatic compression devices, which have proven efficacy in postoperative patients and are recommended for septic patients who cannot receive heparin 6, 8, 9
Combine mechanical with pharmacologic prophylaxis whenever possible in high-risk patients 4, 7

Septic patients present unique challenges due to consumptive coagulopathy and liver dysfunction, creating predisposition for both clotting and bleeding 6, 8

If no contraindications exist, initiate LMWH at standard prophylactic doses 4, 10
If severe renal impairment present, switch to UFH or use dalteparin (renally-adjusted LMWH) 7, 10

Continue prophylaxis throughout the entire hospitalization while risk factors persist 7, 10
Monitor for signs of bleeding in patients receiving pharmacologic prophylaxis 10